Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

After years of preparation, Eli Lilly is on the brink of launching ... developing an add-on device for its existing pen range. Smart insulin pens are expected to drive the insulin pen market ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

At the end of August, Eli Lilly announced it would sell single-use vials of Zepbound directly to patients at a significantly lower price than its injection pens. Affordability is Galindo's top ...

The high court heard arguments Thursday morning on Attorney General Dana Nessel’s effort to investigate and potentially sue the drug company Eli Lilly on the grounds that its insulin pricing ...

Which insulin brands are in shortage and why? Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

Eli Lilly (NYSE: LLY ... Patients self-administer these drugs with an injection pen weekly, but Lilly recently launched single dose vials -- an option that's faster and cheaper for Lilly to ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly insulin efsitora alfa (efsitora) compared to once-daily insulin degludec in ...

Here's why Eli Lilly is a no-brainer stock to buy on ... with sales rising 18% to nearly $880 million. Even Lilly's insulin product Humalog, which was first approved by the U.S. Food and Drug ...